Related Experiment Video
Updated: May 5, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1
Rachel Ziliotto1, Marek R Gruca1, Shreya Podder1
1Department of Microbiology and Immunology and the Centre for Human Immunology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Abstract:
Acute myeloid leukemia (AML) is characterized by increased proliferation and reduced differentiation of myeloid lineage cells. AML is frequently associated with mutations or chromosomal rearrangements involving transcription factors. PU.1 (encoded by Sfpi1) is an E26 transformation-specific family transcription factor that is required for myeloid differentiation. Reduced PU.1 levels, caused by either mutation or repression, are associated with human AML and are sufficient to cause AML in mice. The objective of this study was to determine whether reduced PU.1 expression induces deregulation of the cell cycle in the myeloid lineage. Our results showed that immature myeloid cells expressing reduced PU.1 levels (Sfpi1(BN/BN) myeloid cells) proliferated indefinitely in cell culture and expanded in vivo. Transplantation of Sfpi1(BN/BN) cells induced AML in recipient mice. Cultured Sfpi1(BN/BN) cells expressed elevated messenger RNA transcript and protein levels of E2F1, an important regulator of cell cycle entry. Restoration of PU.1 expression in Sfpi1(BN/BN) myeloid cells blocked proliferation, induced differentiation, and reduced E2F1 expression. Taken together, these data show that PU.1 controls cell cycle exit in the myeloid lineage associated with downregulation of E2F1 expression.
Insights
Reduced PU.1 (Sfpi1) levels drive acute myeloid leukemia (AML) by promoting myeloid cell proliferation and blocking differentiation. This study reveals PU.1 controls cell cycle exit via E2F1 downregulation.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Research
Background:
- Acute myeloid leukemia (AML) is a cancer of myeloid lineage cells, marked by uncontrolled proliferation and impaired differentiation.
- Mutations in transcription factors, including PU.1 (Sfpi1), are frequently implicated in AML development.
- Reduced PU.1 expression is a known factor in human AML and can induce AML in murine models.
Purpose of the Study:
- To investigate if diminished PU.1 expression leads to cell cycle deregulation in myeloid cells.
- To elucidate the molecular mechanisms by which PU.1 influences myeloid cell proliferation and differentiation.
Main Methods:
- Analysis of myeloid cells with reduced PU.1 levels (Sfpi1(BN/BN)) in vitro and in vivo.
- Assessment of cell proliferation, differentiation, and E2F1 expression.
- Transplantation studies in recipient mice to evaluate AML induction.
Main Results:
- Myeloid cells with reduced PU.1 proliferated uncontrollably in culture and expanded in vivo.
- Transplantation of these cells induced AML in mice.
- Reduced PU.1 expression correlated with increased E2F1 (a cell cycle regulator) transcript and protein levels.
- Restoring PU.1 expression halted proliferation, promoted differentiation, and decreased E2F1 levels.
Conclusions:
- PU.1 is essential for controlling cell cycle exit in the myeloid lineage.
- PU.1 exerts its function by downregulating the expression of E2F1.
- Targeting the PU.1/E2F1 pathway may offer therapeutic strategies for AML.
More Related Videos
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
11:40Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Mitogens and the Cell Cycle
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...